Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Cancer Research|October 1, 1986
Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysisD A Cheresh, J Rosenberg, K Mujoo, et al.
Journal of the National Cancer Institute|May 1, 1982
Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levelsD A Cheresh, J A Distasio, C L Vogel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2A Pfeifer, T Kessler, S Silletti, et al.
The Journal of Biological Chemistry|July 25, 1990
Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sitesJ W Smith, Z M Ruggeri, T J Kunicki, et al.
The Journal of Clinical Investigation|June 1, 1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicityB Felding-Habermann, B M Mueller, C A Romerdahl, et al.
The Journal of Cell Biology|June 1, 1992
Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogenD I Leavesley, G D Ferguson, E A Wayner, et al.
Cancer Research|December 1, 1986
Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3P Hersey, S D Schibeci, P Townsend, et al.
Oncogene|September 27, 2006
The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activityM Thullberg, A Gad, A Beeser, et al.
The Journal of Cell Biology|April 1, 1991
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cellsN Kieffer, L A Fitzgerald, D Wolf, et al.
Endocrinology|June 1, 1996
Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunitM Chellaiah, C Fitzgerald, E J Filardo, et al.
Pageof 14